Gioia Iezza

409 total citations
9 papers, 320 citations indexed

About

Gioia Iezza is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Gioia Iezza has authored 9 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Surgery and 3 papers in Oncology. Recurrent topics in Gioia Iezza's work include Thyroid Cancer Diagnosis and Treatment (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Cancer-related Molecular Pathways (2 papers). Gioia Iezza is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (3 papers), Neuroendocrine Tumor Research Advances (2 papers) and Cancer-related Molecular Pathways (2 papers). Gioia Iezza collaborates with scholars based in United States, Australia and Italy. Gioia Iezza's co-authors include Martin McMahon, Roch‐Philippe Charles, Wayne A. Phillips, Elena Amendola, David Dankort, Teruyuki Muraguchi, Joseph Juan, Rosalie C. Sears, Eric A. Collisson and Christy L. Trejo and has published in prestigious journals such as Genes & Development, Cancer Research and Thyroid.

In The Last Decade

Gioia Iezza

9 papers receiving 318 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gioia Iezza United States 7 166 146 129 55 54 9 320
Helen Ding United States 5 145 0.9× 134 0.9× 192 1.5× 24 0.4× 32 0.6× 8 365
Carla Visciano Italy 5 195 1.2× 149 1.0× 99 0.8× 53 1.0× 28 0.5× 5 447
Susanne Lingelbach Germany 10 168 1.0× 139 1.0× 128 1.0× 29 0.5× 21 0.4× 13 348
Patricia Borges de Souza Italy 7 119 0.7× 84 0.6× 223 1.7× 52 0.9× 33 0.6× 12 367
Caroline Pirritt 4 248 1.5× 87 0.6× 180 1.4× 47 0.9× 34 0.6× 5 369
Laura Sánchez-Tejada Spain 9 162 1.0× 155 1.1× 141 1.1× 54 1.0× 14 0.3× 11 378
Florencia Cayrol Argentina 11 173 1.0× 192 1.3× 72 0.6× 42 0.8× 31 0.6× 17 375
Koshi Mimori Japan 10 142 0.9× 150 1.0× 33 0.3× 74 1.3× 75 1.4× 16 361
Thomas Hoelting Germany 14 145 0.9× 109 0.7× 199 1.5× 81 1.5× 16 0.3× 21 460
Xiaoding Liu China 11 126 0.8× 112 0.8× 56 0.4× 50 0.9× 43 0.8× 18 287

Countries citing papers authored by Gioia Iezza

Since Specialization
Citations

This map shows the geographic impact of Gioia Iezza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gioia Iezza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gioia Iezza more than expected).

Fields of papers citing papers by Gioia Iezza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gioia Iezza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gioia Iezza. The network helps show where Gioia Iezza may publish in the future.

Co-authorship network of co-authors of Gioia Iezza

This figure shows the co-authorship network connecting the top 25 collaborators of Gioia Iezza. A scholar is included among the top collaborators of Gioia Iezza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gioia Iezza. Gioia Iezza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Juan, Joseph, Teruyuki Muraguchi, Gioia Iezza, Rosalie C. Sears, & Martin McMahon. (2014). Diminished WNT → β-catenin → c-MYC signaling is a barrier for malignant progression of BRAFV600E-induced lung tumors. Genes & Development. 28(6). 561–575. 60 indexed citations
2.
Charles, Roch‐Philippe, et al.. (2014). Activating BRAF and PIK3CA Mutations Cooperate to Promote Anaplastic Thyroid Carcinogenesis. Molecular Cancer Research. 12(7). 979–986. 83 indexed citations
3.
Trejo, Christy L., Shon Green, Victoria Marsh, et al.. (2013). Mutationally Activated PIK3CAH1047R Cooperates with BRAFV600E to Promote Lung Cancer Progression. Cancer Research. 73(21). 6448–6461. 33 indexed citations
4.
Charles, Roch‐Philippe, Gioia Iezza, Elena Amendola, David Dankort, & Martin McMahon. (2011). Mutationally Activated BRAFV600E Elicits Papillary Thyroid Cancer in the Adult Mouse. Cancer Research. 71(11). 3863–3871. 82 indexed citations
5.
Wang, Yucheng, Gioia Iezza, Marlene Zuraek, et al.. (2010). Lack of NKX2.2 Expression in Bronchopulmonary Typical Carcinoid Tumors: Implications for Patients with Neuroendocrine Tumor Metastases and Unknown Primary Site. Journal of Surgical Research. 163(1). 47–51. 5 indexed citations
6.
Wang, Yucheng, Gioia Iezza, Xiaochen Yuan, et al.. (2008). Homeodomain transcription factor NKX2.2 functions in immature cells to control enteroendocrine differentiation and is expressed in gastrointestinal neuroendocrine tumors. Endocrine Related Cancer. 16(1). 267–279. 31 indexed citations
7.
Bremer, Andrew A., Brian J. Feldman, Gioia Iezza, Orlo H. Clark, & Stephen M. Rosenthal. (2007). Report of a Hürthle Cell Neoplasm in a Peripubertal Girl. Thyroid. 17(2). 175–178. 6 indexed citations
8.
El‐Sayed, Ivan H., David W. Eisele, Tony L. Yang, & Gioia Iezza. (2006). Solitary fibrous tumor of the retropharynx causing obstructive sleep apnea. American Journal of Otolaryngology. 27(4). 259–262. 11 indexed citations
9.
Iezza, Gioia, et al.. (2003). June 2003: 33-year-old male with a frontal lobe mass.. PubMed. 13(4). 643–5. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026